Calza L - Search Results

1

Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir.

Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P. Calza L, et al. AIDS Res Hum Retroviruses. 2021 Mar;37(3):204-206. doi: 10.1089/AID.2020.0117. Epub 2020 Nov 24. AIDS Res Hum Retroviruses. 2021. PMID: 33126811

2

[Systemic lupus erythematosus and HIV infection. A case report and review of the literature].

Calza L, Manfredi R, Colangeli V, Chiodo F. Calza L, et al. Recenti Prog Med. 2002 Jan;93(1):28-31. Recenti Prog Med. 2002. PMID: 11850997 Italian.

3

Hodgkin's disease in the setting of human immunodeficiency virus infection.

Calza L, Manfredi R, Colangeli V, Dentale N, Chiodo F. Calza L, et al. Scand J Infect Dis. 2003;35(2):136-41. doi: 10.1080/0036554021000026994. Scand J Infect Dis. 2003. PMID: 12693568

4

Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy.

Calza L, Manfredi R, Colangeli V, D'Antuono A, Passarini B, Chiodo F. Calza L, et al. Int J STD AIDS. 2003 May;14(5):356-9. doi: 10.1258/095646203321605585. Int J STD AIDS. 2003. PMID: 12803945

5

Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.

Calza L, D'Antuono A, Marinacci G, Manfredi R, Colangeli V, Passarini B, Orioli R, Varoli O, Chiodo F. Calza L, et al. J Am Acad Dermatol. 2004 Mar;50(3):461-5. doi: 10.1016/j.jaad.2003.10.005. J Am Acad Dermatol. 2004. PMID: 14988693

6

First-line efavirenz versus lopinavir-ritonavir-based highly active antiretroviral therapy for naive patients.

Manfredi R, Calza L, Chiodo F. Manfredi R, et al. Among authors: calza l. AIDS. 2004 Nov 19;18(17):2331-3. doi: 10.1097/00002030-200411190-00017. AIDS. 2004. PMID: 15577549

7

Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia.

Calza L, Manfredi R, Colangeli V, Tampellini L, Sebastiani T, Pocaterra D, Chiodo F. Calza L, et al. AIDS. 2005 Jul 1;19(10):1051-8. doi: 10.1097/01.aids.0000174451.78497.8f. AIDS. 2005. PMID: 15958836 Clinical Trial.

8

Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study.

Calza L, Colangeli V, Manfredi R, Legnani G, Tampellini L, Pocaterra D, Chiodo F. Calza L, et al. AIDS. 2005 Jul 1;19(10):1103-5. doi: 10.1097/01.aids.0000174458.86121.43. AIDS. 2005. PMID: 15958843

9

Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.

Calza L, Manfredi R, Colangeli V, Pocaterra D, Pavoni M, Chiodo F. Calza L, et al. Curr HIV Res. 2008 Nov;6(6):572-8. doi: 10.2174/157016208786501481. Curr HIV Res. 2008. PMID: 18991624 Clinical Trial.

10

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.

Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A; ARCA Collaborative Group. Zazzi M, et al. J Antimicrob Chemother. 2009 Sep;64(3):616-24. doi: 10.1093/jac/dkp252. Epub 2009 Jul 19. J Antimicrob Chemother. 2009. PMID: 19620134 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters